发明名称 |
Controlled release formulations of levodopa and uses thereof |
摘要 |
The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor. |
申请公布号 |
US9089608(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201314030792 |
申请日期 |
2013.09.18 |
申请人 |
Impax Laboratories, Inc. |
发明人 |
Hsu Ann;Kou Jim H.;Alani Laman Lynn |
分类号 |
A61K9/24;A61K9/26;A61K47/12;A61K9/16;A61K9/20;A61K9/28;A61K9/50;A61K31/137;A61K31/198;A61K45/06;C07C229/36;A61K9/00;A61K31/197;A61K47/34;A61K47/38 |
主分类号 |
A61K9/24 |
代理机构 |
Florek & Endres PLLC |
代理人 |
Florek & Endres PLLC |
主权项 |
1. A controlled release oral solid formulation of levodopa comprising:
a. levodopa, b. a decarboxylase inhibitor, and c. a carboxylic acid that is not (a) or (b), wherein the carboxylic acid of (c) is in a distinct bead from (a) or (b). |
地址 |
Hayward CA US |